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Abstract: The prognosis of patients with pancreatic cancer remains poor; only patients with 
small tumors and complete resection have a chance of a complete cure. Pancreatic cancer 
responds poorly to conventional therapies, including chemotherapy and irradiation. Snail is a 
transcription  factor  that  has  been  associated  with  anti-apoptotic  and  chemoresistant 
properties in pancreatic cancer cells. In this study, we investigated whether knockdown of 
Snail suppresses growth of and/or sensitizes pancreatic  cancer cells to chemotherapeutic 
agents and irradiation through induction of apoptosis. An adeno-associated virus vector was 
used to deliver Snail siRNA and knockdown Snail expression in untreated pancreatic cancer 
cells and in pancreatic cancer cells treated with chemotherapeutic agents or γ-irradiation. 
Our data indicate that our adeno-associated virus vector can efficiently deliver Snail siRNA 
into PANC-1 cells both in vitro and in vivo, resulting in the knockdown of Snail expression 
at the mRNA and protein levels. We further show that knockdown of Snail expression 
results in potent growth suppression of  pancreatic  cancer cells and suppresses xenograft 
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tumor  growth  in  vivo  through  induction  of  apoptosis.  Finally,  knockdown  of  Snail 
expression significantly sensitizes pancreatic cancer cells to chemotherapeutic agents and 
γ-irradiation through induction of apoptosis. In conclusion, our findings indicate that Snail is 
an important modulator of therapeutic responses of pancreatic cancer cells and is potentially 
useful as a sensitizer in pancreatic cancer therapy.  
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1. Introduction 
Pancreatic cancer is a disease with a high mortality rate and short survival, as a result of the high 
incidence of metastatic disease at diagnosis, the fulminant clinical course and a lack of successful 
therapeutic strategies. In addition, the administration of chemotherapeutic agents and irradiation for the 
treatment of advanced disease has failed [1–3].   
Cancer development is a multistage process which involves a number of genetic and epigenetic 
changes  in  the  genes  controlling  cell  survival,  cell  death,  cell-cell  communication, 
cell-microenvironment  interactions  and  angiogenesis  [4–7].  It  has  become  increasingly  clear  that 
abnormalities in cell death pathways play an important role in tumorigenesis and the development of 
resistance to chemotherapy and radiation therapy [8,9]. The majority of the agents used in cancer 
therapy  directly  or  indirectly  damage  DNA  thereby  inducing  apoptosis.  However,  defects  in  the 
apoptotic machinery can lead to multidrug resistance [10–12]. Therapeutic manipulation of apoptotic 
pathways  has  become  an  attractive  target  to  improve  the  clinical  response  of  pancreatic  cancer 
patients [13,14]. 
 
Recently, much attention has been focused on the epithelial-mesenchymal transition [EMT], a key 
event  of  embryogenesis  that  is  observed  in  tumor  cells  and  is  associated  with  increased 
malignancy [15]. EMT is essential for the formation of different tissues and organs during embryonic 
development  [16].  However,  in  adult tissue,  EMT is  inhibited to  maintain epithelial  integrity and 
homeostasis. Aberrant activation of EMT in epithelial tumors usually correlates with the development 
and  recurrence  of  neoplasms  [17].  Several  transcription  factors  have  been  implicated  in  the 
transcriptional repression of the epithelial marker E-cadherin, including zinc-finger proteins of the 
Snail/Slug family, Twist, ZEB1, SIP1, and the basic helix-loop-helix factor E12/E47. Snail was the 
first and most important transcriptional repressor of E-cadherin to be described. Snail was identified in 
Drosophila  as  a  suppressor  of  shotgun  (an  E-cadherin  homolog)  transcription  and  a  regulator  of 
embryogenesis [18,19]. Snail has a central role in morphogenesis, as it is essential for the formation of 
the mesoderm and neural crest, which requires large-scale cell movements in organisms ranging from 
flies  to  mammals.  Absence  of  Snail  is  lethal  due  to  severe  defects  at  the  gastrula  stage  during 
development  [20].  The  fundamental  role  of  Snail  in  EMT  and  breast  cancer  metastasis  involves 
suppression of E-cadherin expression. In fact, overexpression of Snail was recently found in invasive 
breast cancer, hepatocarcinoma and pancreatic cancer [21–23]. Furthermore, the expression of Snail in 
tumor cells is associated with metastasis, tumor recurrence and poor prognosis [21–24].   
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A few studies have focused on the role of Snail during the development of chemoresistance to 
anti-cancer agents in cancer cells. A recent report suggested that Snail may enhance chemoresistance 
of pancreatic cancer cells to 5-fluorouracil (5-FU) or gemcitabine [25]. In addition, it has found by 
Zhuo et al. [26] that Snail depletion sensitizes A549 lung cancer cells to cisplatin, suggesting a critical 
role  for  Snail  in  chemoresistance  to  cisplatin  and  raising  the  possibility  of  Snail  depletion  as  a 
promising approach to lung cancer therapy.   
The purpose of this study was to determine whether suppression of Snail could increase sensitivity 
of PANC-1 cells to the chemotherapeutic agents, 5-FU and gemcitabine, as well as γ-irradiation. RNA 
interference was employed to knockdown Snail expression in PANC-1 cells, and cell viability and 
apoptosis in response to 5-FU or gemcitabine and γ-irradiation were further assessed. Here, we identify 
a role for Snail in resistance to chemotherapy and -irradiation in pancreatic cancer cells.   
2. Materials and Methods 
2.1. Mice and Cells 
Female Nude mice (6–8 weeks of age) were purchased from the Shanghai Animal Center and 
housed in our pathogen-free animal facilities. The animal experiments were carried out in accordance 
with the Guidelines for the Care and Use of Laboratory Animals and the institutional guidelines. The 
human pancreatic cancer cell line PANC-1 was obtained from the American Type Culture Collection 
(Manassas,  VA,  U.S.)  and  was  maintained  in  Dulbecco’s  Modified  Eagle’s  Medium  (DMEM) 
supplemented with 10% fetal bovine serum, penicillin (100 U/mL) and streptomycin (100 U/mL) at 
37 ° C in an atmosphere of 5% CO2.   
2.2. Construction of the Adeno-Associated Virus Vectors and Production of Viral Particles   
siRNA-Snail adeno-associated virus or siRNA-mock adeno-associated virus (rAAV2-siRNA-Snail 
or rAAV2-siRNA-mock) were generated using the pSilencer
TM 2. 1-U6 neo plasmid vectors (Ambion, 
Austin, TX, U.S.). We generated two different siRNA vectors [26]. The following sequences were 
successfully constructed: siRNA-Snail sense: 5’-GAT CCG CCT AAC TAC AGC GAG CTG TTC 
AAG AGA CAG CTC GCT GTA GTT AGG CTT TTT TGG AAA-3’, and antisense: 5’-AGC TTT 
TCC AAA AAA GCC TAA CTA CAG CGA GCT GTC TCT TGA ACA GCT CGC TGT AGT TAG 
GCG-3’. The sequence was submitted to a BLAST search against the human genome sequence to 
ensure  that  only  the  Snail  gene  was  targeted.  The  following  unrelated  nonspecific  scrambled 
oligonucleotide was used as the control: sense: 5’-GAT CCG TAT TGC CTA GCA TTA CGT TTC 
AAG AGA ACG TAA TGC TAG GCA ATA CTT TTT TGG AAA-3’, and antisense: 5’-AGC TTT 
TCC AAA GTA TTG CCT AGC ATT ACG TTC TCT TGA AAC GTA ATG CTA GGC AAT 
ACG-3’. This siRNA sequence does not match any mammalian sequences currently available in online 
databases.  The  siRNA-Snail  and  siRNA-mock  were  cloned  into  the  pGCL-GFP  vector.  The 
pGCL-GFP vectors with siRNA-Snail or siRNA-mock inserts were used as entry clone vectors and 
transferred into the vector pDC316-EGFP-U6 (Invitrogen, Carlsbad, CA, U.S.) using the Gateway 
BamHI and HindIII enzyme mix according to the manufacturer’s directions (Invitrogen) to generate 
pSNAV2-EGFP-siRNA-Snail-U6  or  pSNAV2-EGFP-siRNA-mock-U6.  The  vectors  were  linearized Int. J. Mol. Sci. 2010, 11                         
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with PacI enzyme and transfected into the 293A cell line using Lipofectamine 2000 reagent according 
to the manufacturer’s directions. The 293A cells were maintained in DMEM until a cytopathic effect 
was apparent 5–7 days post-transfection. Cells were collected and lysed by subjecting them to four 
freeze/thaw cycles. The cell debris was pelleted at 3000 rpm for 15 minutes and the supernatant was 
stored at -80 ° C as crude viral lysate. Fifty microliters of crude viral lysate were added into each 293A 
cell culture dish and incubated for 2–3 days until an 80–100% cytopathic effect was observed. The 
rAAV2-siRNA-Snail or rAAV2- siRNA-mock were harvested and purified using the adeno-associated 
virus Mini Purification Kit according to the manufacturer’s directions (Clontech, Mountain View, CA, 
USA)  and  stored  at  -80  ° C.  Titers  of  rAAV2-siRNA-Snail  or  rAAV2-  siRNA-mock  stocks  were 
determined using an adeno-associated virus Rapid Titer Kit according to the manufacturer’s directions 
(Clontech).   
2.3. Evaluation of Transfection Efficiencies 
After transfection of rAAV2-siRNA-mock (MOIs: 250, 100, 25, 5)  for 48 h, the proportion of 
EGFP-expressing  cells  was  measured  by  fluorescence  microscope  according  to
 the  manufacturer’s 
instruction, to give the transfection efficiency.   
2.4. Drug Treatment 
The anticancer drugs 5-FU and gemcitabine used in the study were purchased from Sigma   
(St. Louis, MO, USA). The drugs were dissolved in DMSO and diluted to appropriate concentrations 
with  cell  culture  media.  PANC-1  cells  were  exposed  to  γ-irradiation  at  6  Gy.  For  combination 
treatments, cells were infected with rAAV2-siRNA-Snail or rAAV2-siRNA-mock for 24 hours prior to 
drug treatment or γ-irradiation.   
2.5. In Vitro Induction of Apoptosis and Growth Assays 
After treatment, attached and floating cells were harvested and analyzed for apoptosis by nuclear 
staining with Annexin V/propidium iodide (PI). A minimum of 300 cells were analyzed for each 
treatment. The PI-stained cells were analyzed by flow cytometry. Cell growth was measured using an 
MTT assay in 96-well plates (2,500 cells per well) using the Cell Titer 96 AQueous One Solution 
(Promega, Madison, WI, USA) following the manufacturer’s instructions. A490 nm was measured using 
a Victor III (Perkin-Elmer/Wallace, USA) plate reader. Each experiment was carried out in triplicate 
and repeated at least twice.   
2.6. Hoechst 33342 and PI Staining 
After treatment, cells were trypsinized, fixed in 1% paraformaldehyde in PBS on ice for 15 minutes, 
suspended in ice cold ethanol -20 ° C. Microscopic detection of apoptosis and necrosis was carried out 
in both floating and adherent cells recovered after treatment using nuclear chromatin staining with 
1 μg/mL Hoechst 33342 and 1 μg/mL propidium iodide for 15 minutes at 37 °C . Quantitative analysis 
of staining was obtained by counting the frequency of Hoechst-positive cells per optical field.   Int. J. Mol. Sci. 2010, 11                         
 
4895 
2.7. Western Blotting   
Whole-cell  proteins  were  isolated  with  the  use  of  RIPA  buffer  (150  mmol/L  NaCl, 
0.5% deoxycholic acid, 0.1% SDS, 1% NP 40, 50 mmol/L TRIS [pH 8.0], with protease inhibitors 
0.5 μg/mL aprotinin, 0.1 μg/mL leupeptin, 0.5 μg/mL pepstatin, and 1 mmol/L PMSF), sonicated for 
10 seconds (Virtis; An Sp Inc, Gardiner, NY, USA), and incubated on ice for 20 minutes. Lysates were 
centrifuged at 16, 000 g at 4 ° C for 30 minutes and the supernatant was collected and stored at −70 ° C. 
The  protein  concentration  was  measured  at  595  nm  using  the  Bradford  assay  reagent  (Bio-Rad 
Laboratories, Inc, Hercules, CA, USA). 30 μg of total protein was loaded per well, separated by 7.5% 
to 12% SDS-PAGE and transferred to polyvinylidene difluoride membranes (Bio-Rad Laboratories, 
Inc.) at 150 mA for 16 hours at 4 ° C. The membranes were blocked with 5% nonfat milk in 0.1% 
Tween-20 in phosphate-buffered saline (PBS) and incubated with primary antibodies against Snail 
(rabbit polyclonal, 1:1500; Oncogene Sciences, San Diego, CA, USA) and β-actin (mouse monoclonal, 
1:1000; Zymed, San Francisco, CA, USA) in 0.1% Tween-20 in PBS. The membranes were rinsed 
twice  with  0.1%  Tween  20  in  PBS  for  15  minutes,  then  incubated  with  horseradish  peroxidase 
(HRP)-conjugated goat anti-mouse IgG antibody (1:5000, Oncogene Sciences, San Diego, CA, USA) 
and  HRP-conjugated  donkey  anti-rabbit  IgG  antibody  (1:5000)  for  1  hour  at  room  temperature. 
Membranes were then washed 3 times with 0.1% Tween-20 in PBS for 15 minutes. Immunoblots were 
detected using an electrochemiluminescence kit (Amersham, Piscataway, NJ, USA) and exposed to 
X-OMAT AR film (Kodak, Rochester, NY, USA).   
2.8. RNA Isolation and RT-PCR 
Total RNA was extracted from cells using the TRIzol reagent (Life Technologies, San Diego, CA, 
U.S.) following the manufacturer’s instructions. 2 g of total RNA was used for synthesis of cDNAs 
by reverse transcription (cDNA Synthesis Kit, Invitrogen) following the manufacturer’s instructions. 
cDNA was amplified using 1 L of the reaction products in 25 L with 10 pmol of each primer for 
35 cycles. Each cycle consisted of 30 seconds of denaturation at 94
 ° C, 30 seconds of annealing at 
65 ° C and 60 seconds of extension at 72 ° C. The primers used for cDNA amplification included: Snail 
forward, 5’-TTC CAG CAG CCC TAC GAC CAG-3’ and reverse, 5’-CGG ACT CTT GGT GCT 
TGT GGA-3’; and β-actin forward, 5’-CAA CTG GGA CGA CAT GGA GA-3’ and reverse 5’-CAG 
GCA GCT CGT AGC TCT TC-3’. β-actin was used as the internal control in all reactions.   
2.9. In Vivo Tumor Study 
All animal experiments were approved by the Institutional Animal Care and Use Committee at the 
University of Qingdao. Xenograft tumors were established by s.c. injection of 4 ×  10
6 PANC-1 cells 
into the flanks of 6- to 8-week-old female Nude mice. Tumor treatment was initiated by injecting each 
tumor (50–100 mm
3) with rAAV2-siRNA-Snail or rAAV2-siRNA-mock (1 ×  10
9 plaque-forming units 
in 50 μL of PBS). Each treatment was repeated twice. Tumor growth was monitored three times per 
week using calipers to calculate tumor volumes according to the formula [length ×  width
2]/2.   
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2.10. In Vivo Apoptosis Detection 
Apoptosis was evaluated by terminal transferase dUTP nick end labeling (TUNEL) staining using 
the  Apoptag  Peroxidase  In  Situ  Detection  Kit  S7100  (Chemicon)  according  to  the  manufacturer's 
instructions.  Briefly,  histological  sections  were  deparaffinized,  hydrated  in  deionized  water,  then 
rinsed with PBS. The sections were treated with 20 μg/mL of proteinase K for 15 minutes to digest 
protein, and with 3% H2O2 for 5 minutes to quench endogenous peroxidase activity. After washing 
with PBS, the equilibration buffer was added. The slides were then treated with working strength TdT 
enzyme for 60 minutes at 37 °C . Subsequently, the sections were incubated with preheated working 
strength  Stop  solution  for  10  minutes,  followed  by  peroxidase  conjugated  anti-digoxigenin  for 
30 minutes. The signal was detected with Pierce Metal Enhanced 3,3’-diaminobenzidine (DAB) and 
the sections were counterstained with methyl green (Vector stock solution) or Mayer’s hematoxylin 
and  then  mounted.  Control  slides  were  ordered  from  Serologicals  Corporation.  The  results  were 
obtained using an optical microscope. The percentage of apoptotic cells was calculated as the number 
of apoptotic cells per number of total cells ×  100%.   
2.11. In Vivo Immunohistochemistry 
Frozen sections from Xenograft tumors were consecutively cut into 4–6-μm thick sections for H&E 
staining  for  routine  histological  analysis  and  for  immunohistochemical  studies.  The 
immunohistochemical  staining  was  carried  out  using  the  Histostain-SP  kit  (Zymed).  The  primary 
antibody  was  polyclonal  anti-Snail  antibody  (Santa  Cruz  Biotechnology,  Santa  Cruz,  CA,  USA) 
(dilution  1:100).  Briefly,  after  deparaffinization  and  rehydration,  the  sections  were  boiled  in 
0.01 mol/L citrate buffer pH 6.0 for 15 minutes in a microwave oven. Then sections were immersed in 
3% hydrogen peroxide in methanol for 10 minutes to block the endogenous peroxidase activity and 
incubated with serum blocking solution to block nonspecific binding. The sections were incubated 
with primary antibody at 4 ° C overnight, followed by incubation with biotinylated secondary antibody 
and enzyme conjugate. Staining was developed by addition of DAB chromogen. The sections were 
counterstained with hematoxylin. The results of the immunostaining were assessed microscopically by 
two  pathologists.  Snail-expressing  cells  within  the  tumors  were  counted  and  the  proportion  of 
Snail-positive cells to total tumor cells was calculated.   
2.12. Statistical Analysis 
P values were calculated by Student’s t test or two-way ANOVA using SPSS10.0 software. The 
mean ±  SD are shown in the figures. P < 0.05 was considered to be statistically significant.   
3. Results 
3.1. Adeno-Associated Virus Vector Effectively Delivers Snail-siRNA into Cultured PANC-1 Cells 
Two adeno-associated virus vectors rAAV2-siRNA-Snail and rAAV2-siRNA-mock that contained 
the GFP gene as a control were constructed. PANC-1 cells were infected with rAAV2-siRNA-Snail 
viral  particles  with  different  multiplicity  of  infections  (MOIs).  The  infection  efficiencies  at  the Int. J. Mol. Sci. 2010, 11                         
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following MOIs: 250, 100, 25, 5 and 0 for 48 hours were 86%, 75%, 26%, 18% and 0%, respectively 
(Figure 1). Snail expression was detected by RT-PCR and Western blotting analysis. Both assays 
demonstrated not only a reduction in Snail gene expression in the infected cells, but also showed a 
clear dose-dependent repression of Snail protein expression (Tables 1–2).   
Table 1. RT-PCR analysis for Snail mRNA (n = 3, mean ±  SD).   
Table 2. Western blotting analysis for Snail protein (n = 3, mean ±  SD). 
  Snail/β-actin value 
Group  0 MOI  5 MOI  25 MOI  100 MOI  250 MOI 
siRNA-Snail  0.658 ±  0.034  0.465 ±  0.027  0.321 ±  0.023  0.214 ±  0.020  0.10 ±  0.012 
siRNA-mock  0.721 ±  0.042  0.657 ±  0.036  0.684 ±  0.046  0.703 ±  0.056  0.674 ±  0.049 
siRNA-Snail vs. siRNA-mock; P = 0.0057. 
Figure  1.  EGFP  expression  detection  by  fluorescence  microscope.  Images  of 
EGFP-expressing cells at 25 MOI (top left), 100 MOI (top right), 250 MOI (bottom left), 
and plot of transfection efficiencies: the infection efficiencies at the following MOIs: 250, 
100, 25 and 5 for 48 hours were 86%, 75%, 26% and 18%respectively.   
 
 
  Snail mRNA/β-actin mRNA 
Group  0 MOI  5 MOI  25 MOI  100 MOI  250 MOI 
siRNA-Snail  0.896 ±  0.057  0.506 ±  0.046  0.36 ±  0.028  0.21 ±  0.014  0.12 ±  0.006 
siRNA-mock  0.824 ±  0.053  0.873 ±  0.066  0.904 ±  0.062  0.849 ±  0.067  0.856 ±  0.072 
siRNA-Snail vs. siRNA-mock, P = 0.0023. Int. J. Mol. Sci. 2010, 11                         
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3.2. Knockdown of Snail Significantly Suppresses Growth of PANC-1 Cancer Cells through Induction 
of Apoptosis   
The anti-apoptotic function of Snail (25) prompted us to investigate whether knockdown of Snail 
suppresses pancreatic cancer cell growth. PANC-1 cells were infected with rAAV2-siRNA-Snail or 
rAAV2-siRNA-mock resulting in at least 70% infection as indicated by the GFP signal. After 48 hours, 
cells were analyzed using the MTT assay. rAAV2-siRNA-Snail was found to cause significant growth 
suppression in PANC-1 cells (P = 0.0025), whereas rAAV2-siRNA-mock had virtually no effect on 
cell growth compared to the untreated cells (P = 0.337; Figure 2A). An increased frequency of cells 
infected  by  rAAV2-siRNA-Snail,  but  not  by  rAAV2-siRNA-mock,  underwent  apoptosis  as 
demonstrated by Hoechst 33342 and PI staining and Annexin V/PI expression (Figures 2B, C). These 
data show that Snail knockdown leads to growth suppression and induction of apoptosis in PANC-1 
cancer cells.   
Figure 2. Knockdown of Snail suppresses the growth of pancreatic cancer cells through 
induction  of  apoptosis.  (A)  Cell  growth  was  measured  by  MTT  assay  48  hours  after 
rAAV2-siRNA-Snail  (or  mock)  infection  (100  MOI),  as  described  in  Materials  and 
Methods. Growth of untreated cells was defined as 100%. (B) Following the indicated 
treatments  for  48  hours,  levels  of  apoptosis  were  analyzed  using  annexin-V  staining. 
(C) Following the indicated treatments for 48 hours, levels of apoptosis were examined 
using Hoechst 33324 and PI staining.   
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3.3. Knockdown of Snail Sensitizes PANC-1 Cancer Cells to Chemotherapeutic Agents and γ-Irradiation 
Abnormalities in the regulation of apoptosis have been shown to contribute to the development of 
resistance to chemotherapy and radiation therapy in cancer cells [27,28]. The important anti-apoptotic 
function of Snail suggests that downregulated Snail expression may restore sensitivity of cancer cells 
to anticancer agents. To test this hypothesis, PANC-1 cells were treated with a low dose of rAAV2 
siRNA-Snail (5 MOI) alone or in combination with γ-irradiation or chemotherapeutic agents, including 
5-FU and gemcitabine. rAAV2-siRNA-Snail was found to significantly enhance the growth inhibitory 
effects of these chemotherapeutic drugs and γ-irradiation (Figures 3A, C and D). For example, up to a 
6–7-fold increase in growth suppression was achieved when rAAV2-siRNA-Snail was combined with 
5-FU (Figure 3B). We also determined the IC50 values of the chemotherapeutic agents in PANC-1 cells 
with or without rAAV2-siRNA-Snail and found that rAAV2-siRNA-Snail significantly lowered the 
IC50s of these agents by 4-fold (gemcitabine) to more than 10-fold (5-FU; Table 3). These results show 
that knockdown of Snail significantly sensitizes PANC-1 cells to chemotherapeutic agents.   
Figure  3.  Knockdown  of  Snail  sensitizes  pancreatic  cancer  cells  to  chemotherapeutic 
agents  and  γ-irradiation.  PANC-1  cells  were  treated  with  chemotherapeutic  agents  and 
γ-irradiation, alone or in combination with rAAV2- siRNA-Snail or rAAV2-siRNA-mock 
(5 MOI), as described in Materials and Methods. Cell growth was measured by MTT assay. 
(A, B) Growth inhibition of PANC-1 cells after treatment with chemotherapeutic drugs or 
irradiation  alone.  5-FU,  0.5  μg/mL;  gemcitabine  0.5  μg/mL;  IR,  γ-irradiation,  6  Gy. 
(C, D) Effects  of  different  concentrations  of  the  chemotherapeutic  drugs  on 
rAAV2-siRNA-Snail  or  rAAV2-siRNA-mock  infected  cells  on  cell  growth.  (E,  F)  The 
sensitizing effects of Snail knockdown are mediated by enhanced induction of apoptosis. 
PANC-1 cells were subjected to the indicated treatments and analyzed for apoptosis, as 
described in Materials and Methods. rAAv was used at 10 MOI. Apoptosis was analyzed 
by Annexin V/PI assays. 5-FU, 0.5 μg/mL; γ-irradiation, 6 Gy.   
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Figure 3. Cont. 
   
Table  3.  IC50  of  the  chemotherapeutics  in  PANC-1  cells  with  or  without 
rAAV2- siRNA-Snail. 
Drug gemcitabine 5-FU 
IC50 
rAAV2- siRNA-mock  rAAV2- siRNA-Snail 
37.4 µg/mL  9.16 µg/mL 
68.57 µg/mL  7.46 µg/mL 
We  next  determined  whether  knockdown  of  Snail  sensitizes  PANC-1  cells  to  these  anticancer 
agents through induction of apoptosis. PANC-1 cells are resistant to apoptosis induced by 5-FU (up to 
5 μg/mL) and γ-irradiation (up to 6 Gy, data not shown). rAAV2-siRNA-Snail (10 MOI) infected cells 
and  5-FU  (0.5  μg/mL)  treated  cells  alone  did  not  induce  significant  apoptosis  in  PANC-1  cells 
(Figure 4A).  However,  almost  70%  of  cells  underwent  apoptosis  following  72  hours  of  the 
combination  treatment  (Figure  3A).  Similarly,  a  combination  of  γ-irradiation  (6  Gy)  with 
rAAV2-siRNA-Snail led to a markedly enhanced apoptotic response in PANC-1 cells (Figure 3E). In 
contrast, the control rAAV2-siRNA-mock had no effect on apoptosis when combined with 5-FU or 
γ-irradiation  (Figures  3E,F).  Analysis  of  apoptosis  levels  using  Hoechst  33342  and  PI  staining 
confirmed  these  results  (data  not  shown).  These  results  show  that  knockdown  of  Snail  promoted 
apoptosis induced by 5-FU or γ-irradiation.   
3.4. Knockdown of Snail Suppresses Tumor Growth in Vivo 
To determine whether the knockdown of Snail confers antitumor activity in vivo, PANC-1 xenograft 
tumors (∼50–100 mm
3) were treated with three injections of rAAV2-siRNA-Snail and the control 
rAAV2-siRNA-mock at 1 ×  10
9 plaque-forming units (Figure 4A). rAAV2-siRNA-mock did not have 
any effect on tumor growth compared with PBS alone, with tumors reaching eight-times their initial 
volume in 21 days (Figures 4 A). In contrast, tumors subjected to rAAV2-siRNA-Snail treatment grew 
much  slower  and  reached  less  than  twice  their  initial  volume,  with  approximately  80%  growth 
suppression  compared  to  tumors  treated  with  rAAV2-siRNA-mock  (P  <  0.01;  Figures  4A).  We 
analyzed tumor histology by H&E staining, Snail protein expression by immunohistochemistry and 
in situ apoptosis by TUNEL. We found that Snail protein expression was inhibited significantly in Int. J. Mol. Sci. 2010, 11                         
 
4901 
rAAV2-siRNA-Snail  treated  tumors  (Figure  4B).  These  data  show  that  knockdown  of  Snail  can 
effectively inhibit growth of established tumors in vivo through induction of apoptosis.   
Figure  4.  Knockdown  of  Snail  suppresses  the  growth  of  xenograft  pancreatic  tumors. 
(A) PANC-1  tumors  (n  =  6  per  group)  were  subjected  to  rAAV2-siRNA-Snail  or 
rAAV2-siRNA-mock  treatment  for  21  days,  as  described  in  Materials  and  Methods. 
(B) Tumor histology was analyzed by H&E staining (top panel). Frozen sections of the 
PANC-1  tumors  48  hours  after  the  second  injection  were  analyzed  by  TUNEL  to 
determine the level of apoptosis (middle). Snail protein expression levels were analyzed by 
immunohistochemistry (bottom). Magnification × 200. 
 




In addition to its role as an inducer of EMT and cell migration, Snail is considered to be a critical 
factor in cell survival [29]. When stably expressed in epithelial cells, Snail confers resistance to cell 
death induced by withdrawal of growth factors and by pro-apoptotic signals [30]. Aberrant expression 
of  Snail  may  also  promote  resistance  to  programmed  cell  death  elicited  by  DNA  damage  [31]. 
Pancreatic  cancer  is  a  malignancy  that  resists  nearly  all  present  chemotherapeutic  strategies. 
Yin et al. [25] reported that expression of Snail not only confers the invasive phenotype to pancreatic 
cancer cells, but also promotes chemoresistance. Therefore, in this study, we have used
 a pancreatic 
cell line, PANC-1 to examine whether knockdown of Snail suppresses growth of pancreatic cancer 
cells and/or sensitizes pancreatic cancer cells to chemotherapeutic agents and irradiation.   
We first examined the efficiency of adeno-associated virus transduction and the effect of MOI on 
the expression level of Snail in pancreatic cancer cells in vitro using RT-PCR and Western blotting. 
We found that the expression of Snail in PANC-1 cells after knockdown by adeno-associated virus 
vectors is clearly viral particle dose-dependent. Higher MOIs resulted in a marked decrease in the 
expression level of Snail protein and mRNA.   
We also demonstrated that knockdown of Snail via adeno-associated viruses resulted in apoptosis 
and  enhanced  sensitivity  to  chemotherapeutic  agents  and  γ-irradiation,  suggesting  that  Snail 
knockdown is crucial for triggering apoptotic responses to these agents. Interestingly, knockdown of 
Snail seems to be the most effective in enhancing growth suppression and apoptosis when combined 
with 5-FU, gemcitabine or γ-irradiation, consistent with the notion that Snail plays a critical role in 
DNA damage–induced apoptosis [26]. These observations suggest that knockdown of Snail sensitizes 
pancreatic cancer cells to chemotherapeutic agents and irradiation, and warrants further evaluation.   
We also investigated the in vivo therapeutic effect of adeno-associated virus-mediated Snail siRNA 
knockdown by intratumoral injections of viruses. Our results show that on average, tumors treated with 
rAAv-siRNA-Snail  were  42%  smaller  than  mock-treated  tumors.  Tumor  volumes  of  the 
rAAv-siRNA-Snail treated group were significantly smaller on day 21 (P < 0.01) than the other groups. 
This  reduction  in  tumor  size  can  be  attributed  to  increased  apoptosis  in  tumors  treated  with 
rAAv-siRNA-Snail.   
5. Conclusion 
We successfully down-regulated Snail expression in PANC-1 cells using adeno-associated Snail 
siRNA  vectors,  resulting  in  increased  5-FU,  gemcitabine  or  γ-irradiation-induced  PANC-1  cell 
apoptosis. These results suggest that appropriate chemotherapeutic or radiation therapies concomitant 
with Snail depletion might be a promising approach to treat pancreatic cancer.   
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